Adviser Accountability and the RDEC Claims Regime

The UK’s R&D tax advice landscape has undergone a fundamental transformation. As longstanding R&D advisers we've experienced this first-hand. What was once a regime governed by broad assumptions and advisory latitude has shifted into a high-scrutiny environment defined by traceability and granular evidence.

As HMRC intensifies its focus on claim integrity, the standard for R&D consultancy has risen: defensibility is no longer a "best practice"—it is the prerequisite for a sustainable claim. The era of aggressive optimisation is being replaced by an era of disciplined compliance. For businesses relying on successful RDEC claims, the question is no longer just about identifying qualifying expenditure; it is about building a robust, audit-ready narrative that withstands rigorous scrutiny. In this analysis, we examine how the shift toward data-driven enforcement is redefining the adviser-claimant relationship and what true defensibility looks like in the current market.

The question is no longer whether the R&D compliance regime is changing. It already has. The question is how that change is now shaping behaviour in practice and what that means for R&D claimant companies.

The variation in adviser quality has always existed, but it is now far harder to ignore.

At its strongest, advisory work is grounded in identifying genuine technological uncertainty, careful interpretation of HMRC guidance and disciplined, evidence-led analysis of projects and costs. At its weakest, it becomes retrospective justification—stretching definitions, expanding boundaries and including costs based on a cursory analysis of accounts, rather than clear qualification assessment.

What has changed is not the R&D advisory spectrum itself, but the level of scrutiny applied to it.

From oversight to R&D agent traceability - a seismic shift

The introduction of the R&D Additional Information Form, mandatory identification of agents and a more structured enquiry approach, all point to a regime that is becoming increasingly traceable and data-driven.

This matters because it enables HMRC to identify patterns at scale—where issues originate, which approaches consistently result in weaker claims, and how different advisory methodologies correlate with compliance outcomes.

Once behaviour becomes visible in data, it becomes significantly easier to challenge.

What the New R&D Scrutiny Means for Claimants: Managing Risk

While legal responsibility always sits with the claimant, in practice most businesses rely heavily on their advisor’s interpretation of complex technical legislation.

That reliance is not new, but the consequences are becoming more pronounced.

In many cases, claims are also shaped by how they are managed internally. Where R&D is not captured contemporaneously and instead assembled at year-end, there is often greater reliance on reconstruction rather than detailed technical and cost evidence. In those circumstances, advisers may be working with information that has already lost some of its precision.

Where either the advisory approach or the internal process is weak, claims are now more likely to face scrutiny. And when they do, the impact rarely stops at HMRC correspondence—it extends into technical reassessment, financial review, and often a reduction or withdrawal of relief.

Increasingly, the focus is shifting from optimisation to defensibility from the outset.

What good RDEC advice looks like now

In this environment, choosing an adviser is no longer just about experience or familiarity with the scheme. It is also about how the adviser operates under scrutiny.

A strong starting point is how clearly they help their clients defirne and capture technological uncertainty in practice, not just in principle.

Equally important is evidence. Strong claims are built on contemporaneous technical and financial records—not reconstructed narratives assembled after the fact.

Consistency also matters. A robust methodology should not shift materially between projects without clear justification.

Finally, defensibility is key. A well-prepared claim should withstand review by HMRC, auditors, or internal stakeholders without requiring reinterpretation after submission.

These are not theoretical standards. They are practical indicators of whether an approach is genuinely robust.

An R&D advisory market beginning to separate

As scrutiny increases, the advisory market is likely to divide more clearly.

Some advisors are already adapting—tightening methodologies and prioritising defensibility over volume. Others will find their approaches increasingly exposed as expectations rise.

The result will be a clearer distinction between claims that are simply submitted and those that are genuinely sustainable.

A final reflection on the R&D advisory sector

The UK’s R&D tax relief regime is entering a more mature phase—defined by transparency, structure and enforcement.

For advisers, that means higher standards and greater visibility.

For claimants, it raises a simple but important question:

Would the advice behind your RDEC claim stand up to detailed scrutiny today—not just in principle, but in practice?

Read about Adviser Fees in 2026: What Are You Really Paying For?

Get R&D claim advice and support